BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 14575308)

  • 1. Calpain-1-dependent degradation of troponin I mutants found in familial hypertrophic cardiomyopathy.
    Barta J; Tóth A; Jaquet K; Redlich A; Edes I; Papp Z
    Mol Cell Biochem; 2003 Sep; 251(1-2):83-8. PubMed ID: 14575308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation of human cardiac troponin I G203S and K206Q linked to familial hypertrophic cardiomyopathy affects actomyosin interaction in different ways.
    Deng Y; Schmidtmann A; Kruse S; Filatov V; Heilmeyer LM; Jaquet K; Thieleczek R
    J Mol Cell Cardiol; 2003 Nov; 35(11):1365-74. PubMed ID: 14596793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional consequences of the mutations in human cardiac troponin I gene found in familial hypertrophic cardiomyopathy.
    Takahashi-Yanaga F; Morimoto S; Harada K; Minakami R; Shiraishi F; Ohta M; Lu QW; Sasaguri T; Ohtsuki I
    J Mol Cell Cardiol; 2001 Dec; 33(12):2095-107. PubMed ID: 11735257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of protein kinase C dependent phosphorylation and a familial hypertrophic cardiomyopathy-related mutation of cardiac troponin I on structural transition of troponin C and myofilament activation.
    Kobayashi T; Dong WJ; Burkart EM; Cheung HC; Solaro RJ
    Biochemistry; 2004 May; 43(20):5996-6004. PubMed ID: 15147183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of T142 phosphorylation and mutation R145G on the interaction of the inhibitory region of human cardiac troponin I with the C-domain of human cardiac troponin C.
    Lindhout DA; Li MX; Schieve D; Sykes BD
    Biochemistry; 2002 Jun; 41(23):7267-74. PubMed ID: 12044157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mutation in the N-terminus of troponin I that is associated with hypertrophic cardiomyopathy affects the Ca(2+)-sensitivity, phosphorylation kinetics and proteolytic susceptibility of troponin.
    Gomes AV; Harada K; Potter JD
    J Mol Cell Cardiol; 2005 Nov; 39(5):754-65. PubMed ID: 16005017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ca(2+)-regulatory function of the inhibitory peptide region of cardiac troponin I is aided by the C-terminus of cardiac troponin T: Effects of familial hypertrophic cardiomyopathy mutations cTnI R145G and cTnT R278C, alone and in combination, on filament sliding.
    Brunet NM; Chase PB; Mihajlović G; Schoffstall B
    Arch Biochem Biophys; 2014 Jun; 552-553():11-20. PubMed ID: 24418317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation and mutation of human cardiac troponin I deferentially destabilize the interaction of the functional regions of troponin I with troponin C.
    Li MX; Wang X; Lindhout DA; Buscemi N; Van Eyk JE; Sykes BD
    Biochemistry; 2003 Dec; 42(49):14460-8. PubMed ID: 14661957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation and functional characterization of knock-in mice harboring the cardiac troponin I-R21C mutation associated with hypertrophic cardiomyopathy.
    Wang Y; Pinto JR; Solis RS; Dweck D; Liang J; Diaz-Perez Z; Ge Y; Walker JW; Potter JD
    J Biol Chem; 2012 Jan; 287(3):2156-67. PubMed ID: 22086914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of HCM cTnI mutation R145G on troponin structure and modulation by PKA phosphorylation elucidated by molecular dynamics simulations.
    Lindert S; Cheng Y; Kekenes-Huskey P; Regnier M; McCammon JA
    Biophys J; 2015 Jan; 108(2):395-407. PubMed ID: 25606687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel phosphorylation site, Serine 199, in the C-terminus of cardiac troponin I regulates calcium sensitivity and susceptibility to calpain-induced proteolysis.
    Wijnker PJ; Li Y; Zhang P; Foster DB; dos Remedios C; Van Eyk JE; Stienen GJ; Murphy AM; van der Velden J
    J Mol Cell Cardiol; 2015 May; 82():93-103. PubMed ID: 25771144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac troponin C-L29Q, related to hypertrophic cardiomyopathy, hinders the transduction of the protein kinase A dependent phosphorylation signal from cardiac troponin I to C.
    Schmidtmann A; Lindow C; Villard S; Heuser A; Mügge A; Gessner R; Granier C; Jaquet K
    FEBS J; 2005 Dec; 272(23):6087-97. PubMed ID: 16302972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial hypertrophic cardiomyopathy mutations in troponin I (K183D, G203S, K206Q) enhance filament sliding.
    Köhler J; Chen Y; Brenner B; Gordon AM; Kraft T; Martyn DA; Regnier M; Rivera AJ; Wang CK; Chase PB
    Physiol Genomics; 2003 Jul; 14(2):117-28. PubMed ID: 12759477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monophosphorylation of cardiac troponin-I at Ser-23/24 is sufficient to regulate cardiac myofibrillar Ca
    Martin-Garrido A; Biesiadecki BJ; Salhi HE; Shaifta Y; Dos Remedios CG; Ayaz-Guner S; Cai W; Ge Y; Avkiran M; Kentish JC
    J Biol Chem; 2018 Jun; 293(22):8588-8599. PubMed ID: 29669813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction of the bisphosphorylated N-terminal arm of cardiac troponin I-A 31P-NMR study.
    Schmidtmann A; Lohmann K; Jaquet K
    FEBS Lett; 2002 Feb; 513(2-3):289-93. PubMed ID: 11904166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular insights from a novel cardiac troponin I mouse model of familial hypertrophic cardiomyopathy.
    Tsoutsman T; Chung J; Doolan A; Nguyen L; Williams IA; Tu E; Lam L; Bailey CG; Rasko JE; Allen DG; Semsarian C
    J Mol Cell Cardiol; 2006 Oct; 41(4):623-32. PubMed ID: 16950368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of protein kinase A phosphorylation on signaling between cardiac troponin I and the N-terminal domain of cardiac troponin C.
    Chandra M; Dong WJ; Pan BS; Cheung HC; Solaro RJ
    Biochemistry; 1997 Oct; 36(43):13305-11. PubMed ID: 9341222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation of cardiac troponin I by mammalian sterile 20-like kinase 1.
    You B; Yan G; Zhang Z; Yan L; Li J; Ge Q; Jin JP; Sun J
    Biochem J; 2009 Feb; 418(1):93-101. PubMed ID: 18986304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis associated with a restrictive cardiomyopathy mutant in cardiac troponin T is due to reduced protein stability and greatly increased myofilament Ca2+ sensitivity.
    Parvatiyar MS; Pinto JR
    Biochim Biophys Acta; 2015 Feb; 1850(2):365-72. PubMed ID: 25450489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional analysis of a troponin I (R145G) mutation associated with familial hypertrophic cardiomyopathy.
    Lang R; Gomes AV; Zhao J; Housmans PR; Miller T; Potter JD
    J Biol Chem; 2002 Apr; 277(14):11670-8. PubMed ID: 11801593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.